Compound
    Moderate Evidence

    Hesperidin

    Hesperidin

    TL;DR

    Hesperidin, usually combined with diosmin as micronised purified flavonoid fraction, is a prescription-grade treatment for haemorrhoids and chronic venous disease in much of Europe, with Cochrane-level support for acute haemorrhoidal symptoms.

    Ideal For

    • Acute haemorrhoidal flares
    • Chronic venous insufficiency, leg heaviness and oedema
    • Post-haemorrhoidectomy symptom management
    • Varicose vein symptoms alongside compression therapy

    Avoid If

    • Pregnancy in the first trimester
    • Expecting it to remove varicose veins rather than ease symptoms
    • Undiagnosed rectal bleeding — get that assessed first

    Frequently Asked Questions

    Why is this a prescription drug in Europe?
    Because the micronised diosmin and hesperidin combination has enough trial evidence in chronic venous disease and haemorrhoids to be licensed and included in treatment guidelines there.
    Does it cure varicose veins?
    No. It reduces symptoms — heaviness, aching, swelling — but does not reverse the structural venous damage. Compression and procedural treatment address that.
    Does micronised really matter?
    Yes. These flavonoids are poorly soluble, and micronisation is what makes absorption adequate. The trial evidence uses micronised product.
    How do I dose it for a haemorrhoid flare?
    The studied acute regimen escalates to around 3,000 mg/day for four days, then tapers over the following week. Get any rectal bleeding assessed first.

    Overview

    Hesperidin illustrates how differently the same compound can be regarded on either side of a regulatory border. In the United States it is a citrus bioflavonoid sold with vague antioxidant claims; in France, Italy and much of Europe the micronised purified flavonoid fraction of 90% diosmin and 10% hesperidin is a licensed medicine for chronic venous disease and haemorrhoids, and appears in clinical guidelines. The evidence supports the European view. A Cochrane review of phlebotonics found benefit for oedema and for symptoms of chronic venous insufficiency, and trials in acute haemorrhoidal disease show faster resolution of bleeding, pain and inflammation, with the combination also used to reduce recurrence and post-haemorrhoidectomy symptoms. Micronisation matters: reducing particle size below two micrometres substantially increases absorption of these poorly soluble flavonoids, and the trial evidence uses the micronised product. Hesperidin also has a smaller literature on endothelial function and blood pressure, where effects are modest, and its metabolite hesperetin is a plausible contributor to the vascular benefits attributed to citrus intake generally. Ordinary non-micronised hesperidin capsules are considerably less well supported.

    How It Works

    • Prolongs noradrenaline action on vein walls, raising venous tone
    • Reduces capillary permeability and leukocyte adhesion
    • Increases lymphatic contraction frequency, aiding drainage
    • Micronisation below 2 micrometres markedly improves absorption

    Quick Facts

    • A licensed medicine for venous disease in much of Europe
    • Cochrane support for oedema and venous symptoms
    • Micronised particle size drives absorption
    • Eases haemorrhoid symptoms; does not remove varicose veins

    Benefits & Outcomes

    No linked outcomes yet. Research is ongoing.

    Supporting Research
    5 studies

    Effects of citrus flavanone hesperidin extracts or purified hesperidin consumption on risk factors for cardiovascular disease: an updated meta-analysis of randomized controlled trials

    Score: 8/10
    2024
    meta_analysis
    n=1500

    Huang H, Liao D, He B +2 more

    Hesperidin significantly reduced total cholesterol, LDL cholesterol and inflammatory markers.

    View source

    Hesperidin, a major flavonoid in orange juice, might not affect lipid profile and blood pressure: A systematic review and meta-analysis of randomized controlled clinical trials

    Score: 8/10
    2019
    meta_analysis
    n=800

    Mohammadi M, Ramezani-Jolfaie N, Lorzadeh E +2 more

    Pooled analysis found no statistically significant reduction in systolic or diastolic blood pressure with hesperidin.

    View source

    Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome

    Score: 7/10
    2011
    crossover
    n=24

    Rizza S, Muniyappa R, Iantorno M +8 more

    Hesperidin increased flow-mediated dilation by 24% and reduced circulating inflammatory markers versus placebo.

    View source

    Hesperidin in orange juice improves human endothelial function in subjects with elevated blood pressure and stage 1 hypertension: a randomized, controlled trial (Citrus study)

    Score: 7/10
    2021
    rct
    n=159

    Valls RM, Pedret A, Calderon-Perez L +3 more

    Hesperidin-enriched juice improved endothelial function and reduced systolic blood pressure.

    View source

    Phlebotonics for haemorrhoids

    Score: 7/10
    2012
    systematic_review
    n=1514

    Perera N, Liolitsa D, Iype S +5 more

    Flavonoid preparations reduced bleeding and persisting symptoms in haemorrhoidal disease, but trials were of low methodological quality.

    View source

    Safety Information

    Potential Side Effects

    Generally mild: gastrointestinal upset, nausea, diarrhoea and headache, mostly at the higher acute doses. Well tolerated at maintenance doses.

    Contraindications

    Undiagnosed rectal bleeding requires medical assessment rather than self-treatment. Avoid in the first trimester of pregnancy.

    Drug Interactions

    • Anticoagulants — theoretical additive effect, limited clinical evidence
    • Calcium channel blockers — mild CYP3A4 inhibition reported
    • Statins — theoretical CYP-mediated interaction

    Pregnancy & Breastfeeding

    Pregnancy: Not enough evidence to judge

    Breastfeeding: Not enough evidence to judge

    Dosage Guidelines

    Dosage Used in Studies

    500-1000 mg

    Best Time to Take

    Split into two doses with meals

    Best Form

    Micronised purified flavonoid fraction (90% diosmin, 10% hesperidin)

    Bioavailability

    Poorly water-soluble; micronisation to under two micrometres substantially increases absorption, and gut bacteria convert hesperidin to the absorbable aglycone hesperetin.

    Dosing by Goal

    GoalDoseNotes
    Starting dose1,000 mg/day MPFF split into two doses
    Acute haemorrhoidsUp to 3,000 mg/day for 4 days, then 2,000 mg/day for 3 days, then 1,000 mg/day
    TimingWith meals
    Assessment pointDays for acute haemorrhoidal symptoms; 4-8 weeks for chronic venous disease

    Forms Compared

    MPFF (diosmin + hesperidin)

    1,000 mg/day; the European prescription-grade standard

    Micronised hesperidin

    Better absorbed than standard particle size

    Standard hesperidin

    Poorly soluble and much less well supported

    Hesperidin methyl chalcone

    A more soluble derivative used in some formulas

    Food & Timing

    With meals — absorption of these flavonoids is poor and improves with food.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.